1.6500
22-November-24 16:44:58
15 minutes delayed
Stocks
+0.0500
+3.12%
Today's range
1.5800 - 1.6800
ISIN
N/A
Source
NASDAQ
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
02 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
25 Mar 2024 07:06:46 By Nasdaq GlobeNewswire